Analysis of ocular fluid, namely, molecular analysis of vitreous and/or aqueous fluid; Sales and/or licensing of medical data, namely, sales and/or licensing of ocular data for pharmaceutical and/or drug development; sales and/or licensing of biologic specimens, namely, sales and/or licensing of ocular biological specimens for pharmaceutical and/or drug development; therapeutic analysis, namely, analysis for identifying therapeutic targets; oculomic integrated AI analysis for biomarker identi...